论文部分内容阅读
目的研究沙美特罗丙酸氟替卡松联合噻托溴铵治疗老年慢性阻塞性肺病的临床效果。方法选取60例2012年1月-2013年12月来我院进行治疗的老年慢性阻塞性肺病患者,将其随机分成对照组与试验组,每组各30例患者。试验组的老年慢性阻塞性肺病患者使用沙美特罗丙酸氟替卡松联合噻托溴铵进行诊治,对照组的老年慢性阻塞性肺病患者使用噻托溴铵进行治疗,疗程各6个月,比较两组患者的治疗前后的肺功能情况。结果在60例老年慢性阻塞性肺病患者中,每组各30例老年慢性阻塞性肺病患者,其中经过疗程后的6个月后,试验组的患者肺功能指标FVC,FEV1等显著升高,两组患者具有明显的差异,有统计学意义(P<0.05)。讨论在治疗老年慢性阻塞性肺病临床上,使用沙美特罗丙酸氟替卡松联合噻托溴铵,具有非常强的支气管的扩张效果,可以非常明显的提高患者的肺功能,让慢性阻塞性肺病得到较好的控制,值得在临床医学上的推广。
Objective To study the clinical efficacy of salmeterol fluticasone propionate combined with tiotropium in the treatment of senile chronic obstructive pulmonary disease. Methods Sixty aged patients with chronic obstructive pulmonary disease who were treated in our hospital from January 2012 to December 2013 were randomly divided into control group and trial group, with 30 patients in each group. Elderly patients with chronic obstructive pulmonary disease in the trial group were treated with fluticasone propionate and tiotropium bromide, and the control group of patients with chronic obstructive pulmonary disease treated with tiotropium for 6 months. The two groups were compared Patient’s lung function before and after treatment. Results In 60 elderly patients with chronic obstructive pulmonary disease, each group of 30 elderly patients with chronic obstructive pulmonary disease, after 6 months after treatment, the experimental group of patients with pulmonary function index FVC, FEV1 and so significantly increased, two Group of patients with significant differences, with statistical significance (P <0.05). Discussion In the treatment of senile COPD clinically, the use of salmeterol fluticasone propionate combined with tiotropium has a very strong bronchial dilatation effect, which can significantly improve patients’ lung function and make chronic obstructive pulmonary disease more Good control, it is worth in the promotion of clinical medicine.